Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass
Annals of Thoracic and Cardiovascular Surgery · 2024
DOI: 10.5761/atcs.oa.23-00210 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Binglin Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Cardiopulmonary Bypass, Heart Valve Prosthesis Implantation, Respiration, Artificial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
PURPOSE: The study aims to assess the effects of dexmedetomidine (Dex) pretreatment on patients during cardiac valve replacement under cardiopulmonary bypass. METHODS: For patients in the Dex group (n = 52), 0.5 μg/kg Dex was given before anesthesia induction, followed by 0.5 μg/kg/h pumping injection before aortic occlusion. For patients in the control group (n = 52), 0.125 ml/kg normal saline was given instead of Dex. RESULTS: The patients in the Dex group had longer time to first dose of rescue propofol than the control group (P = 0.003). The Dex group required less total dosage of propofol than the control group (P = 0.0001). The levels of cardiac troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), malondialdehyde (MDA), and tumor necrosis factor-α (TNF-α) were lower in the Dex group than the control group at T4, 8 h after the operation (T5), and 24 h after the operation (T6) (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
- Pharmacy Intravenous Admixture Services, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Zitieren
APA
Yuan, B., Huang, X., Wen, J., & Peng, M. (2024). Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass. Annals of Thoracic and Cardiovascular Surgery. https://doi.org/10.5761/atcs.oa.23-00210
Vancouver
Yuan B, Huang X, Wen J, Peng M. Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass. Annals of Thoracic and Cardiovascular Surgery. 2024. doi:10.5761/atcs.oa.23-00210
BibTeX
@article{Yuan2024,
author = {Yuan, Binglin and Huang, Xiqiang and Wen, Junlin and Peng, Mengzhe},
title = {Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass},
journal = {Annals of Thoracic and Cardiovascular Surgery},
year = {2024},
doi = {10.5761/atcs.oa.23-00210}
}
EUVIMED